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Summary.-Cytosol receptors for 25-hydroxycholecalciferol, oestradiol and pro-
gesterone were measured in human mammary carcinomas. Significant positive
correlations were found between the concentrations of all three receptors.
TISSUE RECEPTORS for a number of
steroids are present in human breast
cancers (McGuire et al., 1975; Horwitz &
McGuire, 1975; Fazekas & MacFarlane,
1977; Teulings et al., 1977). Binding
proteins for 25-hydroxycholecalciferol
(25-OHCC) have been described for all
mammalian nucleated tissues so far exam-
ined (Haddad & Birge, 1975; Haddad
et at., 1976). We examined a number of
breast tumours for the presence of
25-OHCC-binding proteins and correlated
their presence with the presence of recep-
tors for other steroids.
MATERIALS AND METHODS
Standard and labelled hormones.-25-Hy-
droxy [26,27-3H] cholecalciferol (110 Ci/
mmol), [6,7-3H] oestradiol-17P (42 Ci/mmol)
and [1ca,2a-3H] progesterone (49 Ci/mmol)
were obtained from the Radiochemical
Centre, Amersham, U.K.
Non-radioactive oestradiol-17,B, progester-
one and cortisol were obtained from Sigma
Chemical Co., and non-radioactive 25-OHCC
was a gift from Roussel Pharmaceuticals Pty.
Ltd., Australia.
Collection and processing of tissues.-
Human primary mammary carcinomas and
metastases, obtained during mastectomy or
by biopsy, were immediately placed on ice
and obvious adipose tissue was removed. The
specimens were stored in liquid N2 (-196°C)
and thawed just before assay.
Preparation of cytosol solutions.-All steps
were carried out at 0-40C unless otherwise
stated. Finely minced tissue was placed in a
Teflon container, immersed for several
minutes in liquid N2 and pulverized in a
microdismembrator (Braun, Melsungen, Ger-
man Federal Republic). The powder was
transferred to glass centrifuge tubes and sus-
pended in 14 volumes of buffer (0 O1M Tris,
1 5mM EDTA, 0-25M sucrose, 3mM MgC92, 10% glycerol v/v, lmM dithioerythritol)
using a polypropylene micropipette tip con-
nected to a syringe.
The suspension was centrifuged at 27,000 g
for 20 min and the pellet retained for the
estimation ofDNA (Burton, 1956). The super-
natant was centrifuged for 60 min at 230,000 g
in a Beckman L2-65B ultracentrifuge and an
aliquot of the supernatant (referred to as
"cytosol") was assayed for protein by the
Lowry method. The remainder of the cytosol
solution was stirred for 10 min with a suspen-
sion containing charcoal (2.75% w/v) and
dextran T70 (0 275% w/v) at a ratio of
cytosol:charcoal suspension of 10:1. The
mixture was centrifuged at 2000 g for 10 min,
the supernatant was decanted and recentri-
fuged, and the second supernatant was used
for the subsequent steps.
Oestradiol-receptor assay.-Two 500,u1
aliquots of the charcoal-treated supernatant
were incubated for 20 min at 30°C with
[6,7-3H] oestradiol (final concentration
6x 10-8M). One of these contained, in addi-
tion, 6x 10-6M unlabelled oestradiol. The
incubations were continued overnight at
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00C. They were then subjected to charcoal/
dextran separation as described above and
the supernatants were applied to agar gel for
electrophoresis as described by Wagner
(1972). The gels were cut, and each fraction
placed in a counting vial containing 10 ml of
toluene containing 0.3% 2,5-diphenyl oxazole
(PPO) and 0.01% 1,4-bis-2-(-4-methyl-5-
phenyl oxazole)-benzene (POPOP). The gels
were allowed to stand in this fluid overnight,
and after vigorous shaking of the vials the
radioactivity present was counted in a liquid
scintillation counter. All gel fractions were
counted and appropriate corrections were
made for loss of radioactivity during electro-
phoresis.
The difference between the radioactivity
recovered from the "anodal receptor fraction"
(Wagner, 1972) in the presence and absence
of excess unlabelled oestradiol was used to
calculate specific binding. After correcting for
procedural recovery and counting efficiency,
the amount of oestradiol bound to cytosol
was calculated in pmol/mg protein or pmol/
mg DNA using the specific activity as stated
by the supplier. When this method was used
for uteri of oophorectomized mice treated for
2 days with oestradiol (0-1 pug/animal/day),
mean values of 1-37+0-26 pmol/mg protein
or 8.20+0.12 pmol/mg DNA were obtained.
Progesterone-receptor assay.-Two 500il
aliquots were taken from the same cytosol
preparation as used for the oestradiol-
receptor assay. The aliquots were incubated
for 20 min at 0°C in the presence of excess
unlabelled cortisol (final concentration
6x 10-6M). This was followed by the addition
of excess [1,2-3H] progesterone (final concen-
tration 6 x 10-8M) to both aliquots and
6 x 10-6M unlabelled progesterone to one of
them. At the end of a further incubation at
0°C for 18-20 h the mixtures were treated
with charcoal/dextran and the supernatant
subjected to agar-gel electrophoresis as
described for the oestradiol receptor assay.
Radioactivity was measured in the gel frac-
tions and specific binding calculated as
described for the oestradiol receptor assay.
25-Hydroxycholecalciferol (25-OHCC) recep-
tor assay.-Two 500,u1 aliquots were taken
from the same cytosol preparations as used
for the oestradiol and progesterone-receptor
assays. [3H]25-hydroxycholecalciferol was
added in 50 ,u of ethanol to each of the two
500,ut aliquots of cytosol (final concentration
6x 10-8M). One of these also contained
6 x 10-6M unlabelled 25-OHCC. The incuba-
tions were carried out at 4°C for 1 h with con-
stant agitation. The mixtures were then
treated with charcoal/dextran and the super-
natant subjected to agar-gel electrophoresis
as described for the oestradiol-receptor assay.
In initial experiments the gels were sliced
into 3mm sections before counting. It was
found that [3H]25-OHCC moved only a short
distance from the site of application after
incubation with normal human serum. After
incubation with cytosol from breast cancers
it moved further towards the anode (Fig. 1).
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FIG. 1. Electrophoretic separation of 25-
OHCC-binding proteins in a human mam-
mary-tumour cytosol preparation from
binding proteins in normal human serum.
* 0 (3H) 25-OHCC binding to human
mammary-tumour cytosol.
A A (3H) 25-OHCC binding to normal
human serum.
[3H]25-OHCC applied tothe gel inthe absence
of protein moved towards the cathode. The
difference between the radioactivity re-
covered from Fractions +3 to +5 (Fig. 1) in
the presence and absence of excess unlabelled
25-OHCC was defined as due to 25-OHCC
tissue receptors.
RESULTS
Results of oestradiol, progesterone and
25-OHCC binding in 30 human mammary
tumours are presented in the Table.
Significant positive correlations were
found between the concentrations (pmol/
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TABLE.-Concentrations of oestradiol, progesterone and 25-hydroxycholecalciferol receptors
in human breast cancer
pmol oestradiol
bound per
A
mg protein
0-22
0-24
0-39
0-23
0-09
0-19
0-27
0-60
0-65
0-53
1-26
0-17
0-50
0-19
0-30
0-08
0 35
0-13
0-07
0-30
0-40
0-17
0-14
0-21
0-10
1-09
0-52
0-83
0-03
0-07
mg DNA
2-63
3-32
14-25
3-51
0-83
1-57
20-04
5-92
21-79
5-76
19-33
2-99
44-80
2-60
5-92
1-04
25-84
1-96
0 35
6-31
3-24
1-77
1-68
4-88
1-07
8-77
10-97
7-64
1-80
1-89
pmol progesterone
bound per
mg protein
1-29
0-42
1-59
1-08
0-23
1-26
1-20
1-40
4-06
2-16
4-35
0-17
0-57
0-32
0 70
0-18
0-47
0-18
0-14
0-32
0-58
0-42
0-29
0-33
0-19
1-13
0-68
1-09
006
0-18
mg DNA
15-26
5-82
57-84
16-78
1-89
10-19
89-96
13-86
136-73
23-60
66-86
5-80
51-40
4-47
13-90
2-20
34-99
2-75
0-67
6-80
4-72
4-54
3-60
7-65
1-93
9-10
14-51
10-02
3-14
5-15
pmol 25-OHCC
bound per
mg protein mg DNA
1-37 16-15
1-24 17-07
2-30 83-59
1-39 21-57
1-23 10-25
1-83 14-80
1-51 113-01
2-10 20-76
2-90 97-70
2-09 22-90
4 50 69-11
1-14 19-71
1-78 160-00
1-13 15-77
4-35 86-67
0-53 6-49
1-58 117-87
1-32 20-62
0-47 2-22
1-17 24-89
1-43 11-58
1-01 10-81
0-83 10-20
1-13 26-03
0-56 5-64
3-32 26-80
1-50 31-94
4-51 41-62
1-12 59-17
0-88 24-67
mg protein) ofoestradiol and progesterone
receptors (r=0-718, P<0-01), between
the concentrations of oestradiol and 25-
OHCC receptors (r 0-805, P<0-01, Fig. 2)
and between the concentrations of pro-
gesterone and 25-OHCC receptors (r=
0-641, P<001). When the concentrations
of receptors were expressed as pmol/mg
DNA, the correlation coefficients were
r-0-697, P<0.01 for oestradiol and pro-
gesterone, r=0-909, P<0*01 for oestradiol
and 25-OHCC and r=0-714, P<0-01 for
progesterone and 25-OHCC.
There was no correlation between the
binding of oestradiol or progesterone and
the total protein of the cytosol solution or
the DNA concentrations of the pellet.
However, a significant positive correlation
(r=0-570, P<0-01) was observed between
the concentrations of 25-OHCC receptor
and the total protein of the cytosol
solutions.
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Within the tumour population assayed,
the concentrations of oestradiol and pro-
gesterone receptor (expressed per mg
protein) varied by factors of 42 and 73
respectively. The concentrations of 25-
OHCC receptor varied by a factor of 10.
A Scatchard' nalysis for the binding of
25-OHCC to a cytosol preparation from
one of the tuniours is shown in Fig. 3.
The calculated KD was 1-85x 10-10M.
Sucrose-density-gradient studies (Fig. 4)
showed that the 25-OHCC binding protein
in cytosols obtained from human mam-
mary tumours sedimented with a value
of 6.6OS.
DISCUSSION
Little is known about the factors
responsible for the presence of oestrogen
and progesterone receptors in breast
tumours. Other steroids such as cortisol
and dexamethasone (Fazekas & MacFar-
Patient
FH1
FH2
ES
EMS1
EMS2
ER
DV
EA
MAR
JK
MOR
EK
MG
HW
AS
IB
JB
MC
SC
JG
AG
BG
AM
DM
PN
EN
FR
ET
FW
ES
Total
protein
(mg)
10-89
11-06
7-99
12-90
13-39
10-52
9-21
6-77
4-55
6-29
3-11
8-58
4-50
11-73
4-49
27-36
11-16
20-63
30-10
14-85
12-73
20-65
21-39
16-66
25-90
3-75
9-38
3-69
31-81
22-75
Total
DNA
(mg)
0-92
0-81
0-22
0-83
1-61
1-30
0-12
0-69
0-14
0-58
0-20
0-50
0-05
0-84
0-23
2-25
0-15
1-32
6-30
0-70
1-58
1-93
1-74
0-73
2-55
0-47
0-44
0-40
0-60
0-81
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Fim.. 2.-Correlation between the concentra-
tions of oestradiol receptors and 25-OHCC
receptors in human mammary carcinomas.
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FIG. 3.-Scatchardanalysis of 25-OHCC bind-
ing to cytosol obtained from a human
mammary tumour. Each point is the mean
oftriplicate estimations.
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FiG. 4.-Sucrose-density gradient (5-20%
w/v) of 25-OHCC-binding protein from a
human mammary-tumour cytosol. The
solid line represents binding of (3H)25-
OHCC in the absence of excess unlabelled
25-OHCC. The broken line represents bind-
ing of [3H]25-OHCC in the presence of
excess unlabelled 25-OHCC.
The gradients were centrifuged for 20 h
at 238,000 (ave) x g using a Beckman
SW50.1 rotor. The calculated sedimenta-
tion coefficient is 6 0S, with bovine serum
albumin (BSA) as reference standard.
lane, 1977) also bind specifically to high-
affinity proteins in such tumours, and it
has been known for some time that the
presence of oestradiol receptors in a
tumour is of value in predicting its res-
ponsetohormonalmanipulations (McGuire
et at., 1975).
The correlation between oestradiol bind-
ing and progesterone binding is not sur-
prising. Progesterone receptor has been
!O shown to be controlled by oestradiol in
classical target tissues such as the uterus
(Toft & O'Malley, 1972; Rael & Shih,
1975) and our finding is consistent with
data presented by other workers (Horwitz
etal., 1975;Pichon &Milgrom, 1977).
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The significance of 25-OHCC receptor in
mammary tumours and its correlation
with the two sex-steroid receptors is not
clear. Van Baelen et at. (1977) reported
that 25-OHCC tissue-binding protein
appeared in the cytosol obtained from rat
kidney-cell cultures only after the cytosol
had been incubated with [3H]25-OHCC
prelabelled rat serum. These authors
therefore suggested that the 25-OHCC
receptor is only an "artefact" due to
plasma contamination of tissue during the
preparation of cytosol fractions. The
correlation between oestrogen receptor
and 25-OHCC receptor obtained in this
study and the increase in 25-OHCC-
binding protein in mouse uteri but
not in mouse kidneys after oestradiol
administration(Murphy etal.,unpublished)
appear to iindicate that the 25-OHCC-
receptor protein in breast tissue is more
than an artefact. It is not kniown whether
the presence of the 25-OHCC recep-
tor in tumour tissue has biological sig-
nificance. Many substances bind speci-
fically to cytosol receptors without
apparent physiological affects (Funder,
1978). On the other hand, high circulat-
ing-oestrogen levels are associated with
high circulating levels of25-OHCC-binding
protein (Haddad & Walgate, 1976) and
other carrier proteins (Westphal, 1971).
It is therefore possible that intracellular
receptors for oestrogen and 25-OHCC share
similar controlling mechanisms.
It appears likely that a family of recep-
tors is induced together by appropriate
stimuli, and that the presence of such
receptors constitutes a reflection ofgreater
cell differentiation with a better prognosis
(McGuire et al., 1978).
This work was supported by a University of
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